Seaman Family MR Research Centre, University of Calgary, Calgary, AB, Canada.
Department of Radiology, University of Calgary, Calgary, AB, Canada.
Clin Transl Gastroenterol. 2018 Jul 6;9(7):169. doi: 10.1038/s41424-018-0038-z.
Behavioral symptoms are commonly reported by patients with primary biliary cholangitis (PBC). In other patient populations, symptoms are commonly associated with hippocampal volume reduction linked to neuroinflammation (inferred from regional iron deposition), as demonstrated by magnetic resonance imaging (MRI). We hypothesized that PBC patients would exhibit reduced volume and increased iron deposition of the hippocampus.
Seventeen female non-cirrhotic PBC patients and 17 age/gender-matched controls underwent 3-Tesla T-weighted MRI and quantitative susceptibility mapping (QSM; an indicator of iron deposition). The hippocampus and its subfields were segmented from T images using Freesurfer, and susceptibility of the whole hippocampus was calculated from QSM images. Volume and susceptibility were compared between groups, and associations with PBC-40 score and disease indicators (years since diagnosis, Fibroscan value, alkaline phosphatase level, clinical response to ursodeoxycholic acid (UDCA)) were investigated.
PBC patients exhibited significantly reduced hippocampal volume (p = 0.023) and increased susceptibility (p = 0.048). Subfield volumes were reduced for the subiculum, molecular layer, granule cell layer of the dentate gyrus and CA4 (p < 0.05). Fibroscan value was significantly correlated with PBC-40 (Spearman's rho = 0.499; p = 0.041) and disease duration (Spearman's rho = 0.568; p = 0.017).
Our findings suggest hippocampal changes occur early in the disease course of PBC, similar in magnitude to those observed in major depressive disorder and neurodegenerative diseases.
Clinical management of PBC could include early interventional strategies that promote hippocampal neurogenesis that may beneficially impact behavioral symptoms and improve quality of life.
原发性胆汁性胆管炎(PBC)患者常报告出现行为症状。在其他患者群体中,症状通常与神经炎症相关的海马体体积缩小有关(通过磁共振成像[MRI]推断存在区域性铁沉积)。我们假设 PBC 患者会表现出海马体体积缩小和铁沉积增加。
17 名非肝硬化 PBC 女性患者和 17 名年龄/性别匹配的对照者接受了 3T T 加权 MRI 和定量磁化率成像(QSM;铁沉积的指标)。使用 Freesurfer 从 T 图像中分割出海马体及其亚区,并从 QSM 图像中计算出海马体的整体磁化率。比较两组间的体积和磁化率,并研究其与 PBC-40 评分和疾病指标(诊断后年限、纤维扫描值、碱性磷酸酶水平、熊去氧胆酸(UDCA)的临床反应)之间的相关性。
PBC 患者的海马体体积显著减小(p=0.023),磁化率显著增加(p=0.048)。亚区体积减小的部位包括:海马伞、分子层、齿状回颗粒细胞层和 CA4(p<0.05)。纤维扫描值与 PBC-40(Spearman's rho=0.499;p=0.041)和疾病持续时间(Spearman's rho=0.568;p=0.017)显著相关。
我们的研究结果表明,PBC 疾病过程早期就会发生海马体变化,其程度与重度抑郁症和神经退行性疾病中观察到的变化相似。
PBC 的临床管理可以包括早期的干预策略,促进海马体神经发生,这可能对行为症状和提高生活质量产生有益影响。